Mrs. Jennifer Kay Anthony, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 116 Corley Cir, Wake Village, TX 75501 Phone: 903-223-8584 |
News Archive
Helen Genova, PhD, received a $599,103 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the three-year study, "Using virtual reality to improve job reentry in adults with traumatic brain injury: a randomized controlled trial." Dr. Genova, principal investigator, is assistant director of the Center for Neuropsychology and Neuroscience Research at Kessler Foundation.
Antibodies are the foot soldiers of our immune system. These specialized, Y-shaped proteins attach to bacteria and viruses, where they either block the pathogen's activity directly, or signal the immune system's cells to destroy the invader.
Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.
Genzyme Corporation today reported four-year follow-up data from its completed Phase 2 multiple sclerosis (MS) trial showing an estimated 71 percent of alemtuzumab treated patients remain free of clinically-active disease as much as three years after most patients received their last course of the investigational compound. The data were presented at the American Academy of Neurology annual meeting.
› Verified 1 days ago